Clinical trial
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in…
NCT00004887 · The Christie NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00004887 |
|---|---|
| Title | Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery |
| Official title | A Randomized Phase III Comparative Study of Paclitaxel With Carboplatin Versus Mitomycin, Ifosfamide, Cisplatin (MIC) Chemotherapy in Inoperable Advanced Stage Non-Small Cell Lung Cancer |
| Lead sponsor | The Christie NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, ifosfamide, mitomycin C, paclitaxel, vinblastine sulfate |
| Start date | Jan 1, 1999 |
| First posted | Jul 24, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: